Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Eli Lilly and Company LLY

Healthcare  —  Drug Manufacturers General
1,183.46 1.57 0.13% as of 25 Sep
Market cap
$1.11T
P/E
39.7×
S&P 500 Member Dividend Aristocrat Revenue Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Eli Lilly and Company (LLY) P/E ratio

As of 25 September 2026, Eli Lilly and Company (LLY) trades at a P/E ratio of 39.7×. Over the past ten years it has ranged from 0.0× (September 2018) to 264× (November 2018); the current reading is higher than 53% of that period. That is above the Drug Manufacturers General industry median of 24.7× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 46.8× (28.97%)
FY2024 65.9× (35.43%)
FY2023 102× 93.02%
FY2022 52.9× 17.58%
FY2021 45.0× 81.18%
FY2020 24.8× 65.87%
FY2019 15.0× (59.51%)
FY2018 37.0× —
FY2017 0.0× —
FY2016 28.9× (22.45%)

Quarterly

Period P/E ratio Change
Jun 2026 40.2× 23.18%
Mar 2026 32.7× (30.22%)
Dec 2025 46.8× 25.44%
Sep 2025 37.3× (26.73%)
42 more quarters

Against its own ten years

Low 0.0× High 264×
Ten-year median 39.2×
Current reading's percentile 53

P/E ratio against peers

Company P/E ratio
GILD Gilead Sciences, Inc. compare n/m
NVS Novartis AG compare 21.8×
AZN AstraZeneca PLC compare 24.7×
AMGN Amgen Inc. compare 25.6×
JNJ Johnson & Johnson compare 31.4×
PFE Pfizer Inc. compare 37.7×
LLY Eli Lilly and Company 39.7×
ABBV AbbVie Inc. compare 74.7×
MRK Merck & Co., Inc. compare 119×
Drug Manufacturers General industry median 24.7×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on LLY